Full Story →
Uncategorized
Full Story →
Full Story →
Full Story →
Full Story →
Full Story →
Johns Hopkins biomedical engineers have teamed up with clinicians to create a new drug-delivery strategy for a type of central vision loss caused by blood vessel growth at the back of the eye, where such growth should not occur.